CANTALENE, lozenge tablet 24 tablets
Active ingredients: Chlorhexidine acetate, Lysozyme hydrochloride, Tetracaine hydrochloride
Commercialized according to BDPM
Lozenge tablet24 tabletsvoie buccale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CANTALENE, comprimé à sucer
- Pharmaceutical form
- comprimé à sucer
- Route of administration
- voie buccale autre
- Presentation description
- plaquette(s) thermoformée(s) PVC-Aluminium de 24 comprimé(s)
- Marketing authorisation holder
- COOPER (ABRÉGÉ DE COOPERATION PHARMACEUTIQUE FRANCAISE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Jan 1990
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60406856CIP73322158CIP133400933221584Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTATE DE CHLORHEXIDINEcomprimé | 2 mg · un comprimé | SA |
| CHLORHYDRATE DE LYSOZYMEcomprimé | 20 mg · un comprimé | SA |
| CHLORHYDRATE DE TÉTRACAÏNEcomprimé | 0,20 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.